PRN-2246

PRN-2246 is an experimental drug designed to target specific proteins that help certain viruses or diseases, such as HIV, replicate and spread within the body. By inhibiting these proteins, PRN-2246 aims to prevent the virus from multiplying, potentially offering a new treatment option. Currently, it is in the research or trial stage, meaning it’s not yet approved for general medical use. The goal is to develop a medicine that is effective and safe, helping manage or cure infections more efficiently in the future.